Delivery of neurotrophin-3 to the cochlea using alginate beads

Otology and Neurotology

Volumn 26, Issue 3, 2005, Pages 528-533

  Noushi, Farnoosh ^a   Richardson, Rachael T ^b   Hardman, Jennifer ^b   Clark, Graeme ^a,b   O'Leary, Stephen ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BIONIC EAR INSTITUTE   (Australia)

Author keywords

Alginate; Cochlea; Drug delivery; Neurotrophin 3; Sensorineural hearing loss

Indexed keywords

ALGINIC ACID; HEPARIN; NEUROTROPHIN 3; RINGER SOLUTION;

ACOUSTIC NERVE FIBER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIODEGRADABILITY; CELL SURVIVAL; COCHLEA; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GELATION; GUINEA PIG; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; TISSUE REACTION;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; COCHLEA; COCHLEAR NERVE; DEAFNESS; EAR, INNER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GLUCURONIC ACID; GUINEA PIGS; HEXURONIC ACIDS; MICROSPHERES; NEURONS, AFFERENT; NEUROTROPHIN 3; TOXINS, BIOLOGICAL;

EID: 18644372003     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mao.0000169780.84588.a5     Document Type: Article

References (44)

1. Minor LB. Intratympanic gentamicin for control of vertigo in Menière's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
2. Kaasinen S, Pyykko I, Ishizaki H, et al. Intratympanic gentamicin in Menière's disease. Acta Otolaryngol 1998;118:294-8.
3. Hoffer ME, Kopke RD, Weisskopf P, et al. Use of the round window microcatheter in the treatment of Menière's disease. Laryngoscope 2001;111:2046-9.
4. Hoffer ME, Kopke RD, Weisskopf P, et al. Microdose gentamicin administration via the round window microcatheter: results in patients with Menière's disease. Ann N Y Acad Sci 2001;942:46-51.
5. Yang GS, Song HT, Keithley EM, et al. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol 2000;21:499-504.
6. Kopke RD, Hoffer ME, Wester D, et al. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22:475-9.
7. Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142-6.
8. Silverstein H, Arruda J, Rosenberg SI, et al. Direct round window membrane application of gentamicin in the treatment of Menière's disease. Otolaryngol Head Neck Surg 1999;120:649-55.
9. Pasic TR, Rubel EW. Rapid changes in cochlear nucleus cell size following blockade of auditory nerve electrical activity in gerbils. J Comp Neurol 1989;283:474-80.
10. Jackson LE, Silverstein H. Chemical perfusion of the inner ear. Otolaryngol Clin North Am 2002;35:639-53.
11. Brown JN, Miller JM, Altschuler RA, et al. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993;70: 167-72.
12. Schindler JS, Schindler RA. Neurotrophin action in the cochlea: implications for cochlear implants. Adv Otorhinolaryngol 1997;52: 8-14.
13. Ernfors P, Duan ML, ElShamy WM, et al. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 1996;2:463-7.
14. Nair TS, Prieskorn DM, Miller JM, et al. In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody. Hear Res 1997;107:93-101.
15. Lalwani AK, Han JJ, Walsh BJ, et al. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 1997; 114:139-47.
16. Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Del Rev 1998;31:267-85.
17. Edelman ER, Mathiowitz E, Langer R, et al. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991;12:619-26.
18. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100:1865-71.
19. Austin L, Bower JJ, Kurek JB, et al. Controlled release of leukaemia inhibitory factor (LIF) to tissues. Growth Factors 1997;15:61-8.
20. Maysinger D, Jalsenjak I, Cuello AC. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions. Neurosci Lett 1992;140:71-4.
21. Maysinger D, Krieglstein K, Filipovic-Grcic J, et al. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities. Exp Neurol 1996;138:177-88.
22. Suzuki K. Regeneration of transected spinal cord in young adult rats using freeze-dried alginate gel. Neuroreport 1999;10:2891-4.
23. Kataoka K, Suzuki Y, Kitada M, et al. Alginate, a bioresorbable material derived from brown seaweed, enhances elongation of amputated axons of spinal cord in infant rats. J Biomed Mater Res 2001;54:373-84.
24. Sufan W, Suzuki Y, Tanihara M, et al. Sciatic nerve regeneration through alginate with tubulation or nontubulation repair in cat. J Neurotrauma 2001;18:329-38.
25. Sakiyama-Elbert SE, Hubbell JA. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 2000;69:149-58.
26. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000;65:389-402.
27. Tanihara M, Suzuki Y, Yamamoto E, et al. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 2001;56:216-21.
28. Staecker H, Liu W, Hartnick C, et al. NT-3 combined with CNTF promotes survival of neurons in modiolus-spiral ganglion explants. Neuroreport 1995;6:1533-7.
29. Ylikoski J, Pirvola U, Virkkala J, et al. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
30. Zheng JL, Stewart RR, Gao WQ. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J Neurosci 1995;15:5079-87.
31. Malgrange B, Lefebvre P, Van de Water TR, et al. Effects of neurotrophins on early auditory neurones in cell culture. Neuroreport 1996;7:913-7.
32. Mou K, Hunsberger CL, Cleary JM, et al. Synergistic effects of BDNF and NT-3 on postnatal spiral ganglion neurons. J Comp Neurol 1997;386:529-39.
33. Marzella PL, Clark GM, Shepherd RK, et al. Synergy between TGF-beta 3 and NT-3 to promote the survival of spiral ganglia neurones in vitro. Neurosci Lett 1998;240:77-80.
34. Marzella PL, Gillespie LN, Clark GM, et al. The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear Res 1999;138:73-80.
35. Gillespie LN, Clark GM, Bartlett PF, et al. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport 2001;12:275-9.
36. Staecker H, Kopke R, Malgrange B et al. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-94.
37. Miller JM, Chi DH, O'Keeffe LJ, et al. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997;15:631-43.
38. Shepherd RK, Clark GM. Progressive ototoxicity of neomycin monitored using derived brainstem response audiometry. Hear Res 1985;18:105-10.
39. Hardie NA, Shepherd RK. Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem. Hear Res 1999;128:147-65.
40. Richardson R, O'Leary SJ, Wise A, et al. A Single Dose of Neurotrophin-3 to the Cochlea Surrounds Spiral Ganglion Neurons and Provides Trophic Support. Hear Res 2005. In press.
41. Wise A, Richardson R, Hardman J, et al. Resprouting and survival of guinea pig cochlear neurons in response to the administration of neurotrophins BDNF and NT-3. J Comp Neurol 2005. In press.
42. Shinohara T, Bredberg G, Ulfendahl M, et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci USA 2002;99:1657-60.
43. Shepherd R, Serruto A, Epp S et al. Final Report, NIH Contract N01-DC-0-2109: Protective Effects of Patterned Electrical Stimulation on the Deaf Auditory System. Victoria, Australia: Department of Otolaryngology, University of Melbourne, Parkville, 2003.
44. Ohta M, Suzuki Y, Chou H, et al. Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve. J Biomed Mater Res 2004;71A:661-8.